Features
Tips and Tricks for Durysta Injection
Put new procedures in place for sustained-release therapy.
By E. Randy Craven, MD
An Update on 24-Hour Glaucoma Monitoring
Current approaches reveal remaining challenges.
By Kaweh Mansouri, MD, MPH, Kevin Gillmann, MD, MBBS, FEBOphth, MArch
Surgical Management of Primary Congenital Glaucoma
Achieving the goal of lifelong vision.
By Hamed Esfandiari, MD
Practical Tips on OCT in Glaucoma
Review the options, uses, and common artifacts.
By Sanjay Asrani, MD, Matthew Duggan, MD
Web Exclusives
Glauconix Offers Services to Facilitate Drug Development
Human tissue models save time and money.
By Jerry Helzner, contributing editor
Departments
From the Editor: Glaucoma Therapy's Fourth Pillar
By Nathan M. Radcliffe, MD
Dogma vs Data: Prostaglandin Use in Glaucoma Patients With Uveitis
Do prostaglandins increase risk of uveitis flares, macular edema, and herpetic keratouveitis?
By Debra A. Goldstein, MD, Jennifer Lee, MD
Case Files: MIGS in a Glaucoma Patient With Prior Incisional Surgery
Can MIGS be a "Goldilocks" option for refractory glaucoma?
By Brandon Baartman, MD
Product Spotlight: Delivering Treatments Right on the Mark
Nidek's newly upgraded laser ensures precise targeting of pathology.
By Karen Appold, contributing writer
News
Personalized Coaching Improves Medication Compliance
By Jerry Helzner, contributing editor
Study Reveals How the Eye Regulates IOP
By Jerry Helzner, contributing editor
Implandata Launches Remote IOP Monitoring
By Jerry Helzner, contributing editor
MicroPulse Effective in Trans-scleral Cyclophotocoagulation
By Jerry Helzner, contributing editor
Sight Sciences Introduces Improved OMNI System
By Jerry Helzner, contributing editor
Efficacy of SLT as First-Line Therapy
By Jerry Helzner, contributing editor
Identifying Cell Degeneration in Glaucoma
By Jerry Helzner, contributing editor
FDA Will Review Santen MicroShunt
By Jerry Helzner, contributing editor
Quantel Completes Acquisition of Ellex
By Jerry Helzner, contributing editor
iStent Shows 6-Year Effectiveness
By Jerry Helzner, contributing editor
iStent inject Effective in Normal-Tension Glaucoma
By Jerry Helzner, contributing editor
Effect of Diet on Glaucoma Prevention
By Jerry Helzner, contributing editor
First Eye Success With Xen Predicts Fellow Eye Success
By Jerry Helzner, contributing editor
Vitamin B3 Shows Potential in Protecting Against Glaucoma Damage
By Jerry Helzner, contributing editor
Virus Adversely Affects Elective MIGS Procedures
By Jerry Helzner, contributing editor
New App Covers Ophthalmic Acronyms
By Jerry Helzner, contributing editor